Clinical Trial Update: Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and immunomodulation of simultaneous HPV and HBV vaccination was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• HBV vaccine (hepatitis B vaccine)
• HPV vaccine

Snippet

Sponsor: National Institute for Public Health and the Environment (RIVM) | Conditions: Human Papillomavirus Infection | Phase 4 | Status: TERMINATED